Heska to Present at Upcoming Conferences in February and March 2021
LOVELAND, Colo., Feb. 16, 2021 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty products, announced that Kevin Wilson, Heska's President and Chief Executive Officer, will present at the following upcoming conferences in February and March 2021:
February 25, 2021 ? Bank of America Securities 2021 Virtual Animal Health Summit. Mr. Wilson will present at 9:00 a.m. ET. The presentation webcast can be accessed at http://www.veracast.com/webcasts/bofa/animalhealth2021/idhK1lyO.cfm and the replay will be archived for 90 days following the event. Mr. Wilson and other members of Heska's management team will also participate in one-on-one meetings on February 25.
March 1, 2021 ? Raymond James Virtual 42nd Annual Institutional Investors Conference. Mr. Wilson will present at 3:50 p.m. ET. The presentation webcast can be accessed at https://kvgo.com/rjinstitutionalinvestors/heska-corporation-march-2021 and the replay will be archived for 90 days following the event. Mr. Wilson and other members of Heska's management team will also participate in one-on-one meetings on March 1.
March 9, 2021 ? Barclays Global Healthcare Conference. Mr. Wilson will present at 4:10 p.m. ET. The presentation webcast can be accessed at https://kvgo.com/2021-global-healthcare-conference/heska-corp-march-2021 and the replay will be archived for 90 days following the event. Mr. Wilson and other members of Heska's management team will also participate in one-on-one meetings on March 9.
For questions and more information, please contact Heska Investor Relations at [email protected].
About Heska Heska Corporation (NASDAQ: HSKA) manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production under third-party agreements and channels, primarily for herd animal health.
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards.
"This product, along with our other innovations,...
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...
StateHouse Holdings Inc. ("StateHouse" or the "Company") , a California-focused, vertically integrated cannabis company, today announced further to its press release dated April 15, 2024, that the Ontario Securities Commission (the "OSC") has denied...